Resolve Therapeutics Lands $1,083,334 New Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=62ba0bdd-bfdb-4ba8-aef8-aadfacaa7af6&Preview=1 -
Date
4/26/2012 -
Company Name
Resolve Therapeutics -
Mailing Address
5400 Carillon Point Kirkland, WA 98033 -
Company Description
Resolve Therapeutics is a privately held biotechnology company based in Seattle that is dedicated to helping patients with lupus through the development of RSLV-125, its novel targeted biologic therapy. -
Website
http://www.resolvebio.com -
Transaction Type
Debt -
Transaction Amount
$1,083,334 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
